Analysis of Serum Protein Glycosylation with Antibody–Lectin Microarray for High-Throughput Biomarker Screening

Part of the Methods in Molecular Biology book series (MIMB, volume 723)


The complexity of carbohydrate structures and their derivatives makes the study of the glycome a challenging subset of proteomic research. The microarray platform has become an essential tool to characterize glycan structure and to study glycosylation-related biological interactions, by using probes as a means to interrogate the spotted or captured glycosylated molecules on the arrays. The high-throughput and reproducible nature of microarray platforms have been highlighted by their extensive applications in the field of biomarker validation, where a large number of samples must be analyzed multiple times. This chapter presents an antibody–lectin microarray approach, which allows the efficient, multiplexed study of the glycosylation of multiple individual proteins from complex mixtures with both fluorescence labeling detection and label-free detection based on mass spectrometry.

Key words

Microarray Antibody Glycoprotein Biomarker Serum Lectin MALDI Mass spectrometry 



Our work on microarray development described herein has been supported in part under grants from the National Cancer Institute under grant NCI R21 12441, R01 CA106402. This work has also received partial support from the National Institutes of Health under R01GM49500.

We would like to thank Dr. Brian Haab and Dr. Chen Songming of the Van Andel Institute for sharing with us the procedures of preparing the antibody arrays. We would also like to thank Stephanie Laurinec, Jes Pedroza, and Missy Tuck for collection of the samples used in this work.


  1. 1.
    Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA (2001) Glycosylation and the immune system. Science 291:2370–2376PubMedCrossRefGoogle Scholar
  2. 2.
    Kobata A, Amano J (2005) Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol 83:429–439PubMedCrossRefGoogle Scholar
  3. 3.
    Gessner P, Riedl S, Quentmaier A et al (1993) (1993) Enhanced activity of cmp-newac-gal-beta-1–4glcnac-alpha-2, 6-sialyltransferase in metastasizing human colorectal tumor-tissue and serum of tumor patients. Cancer Lett 75:143–149PubMedCrossRefGoogle Scholar
  4. 4.
    Gorelik E, Galili U, Raz A (2001) On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev 20:245–277PubMedCrossRefGoogle Scholar
  5. 5.
    Zhao J, Simeone DM, Heidt D, Anderson MA, Lubman DM (2006) Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum. J Proteome Res 5:1792–1802PubMedCrossRefGoogle Scholar
  6. 6.
    Ressom HW, Varghese RS, Goldman L et al (2008) Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J Proteome Res 7:603–610PubMedCrossRefGoogle Scholar
  7. 7.
    An HJ, Peavy TR, Hedrick JL et al (2003) (2003) Determination of N-glycosylation sites and site heterogeneity in glycoproteins. Anal Chem 75:5628–5637PubMedCrossRefGoogle Scholar
  8. 8.
    Block TM, Comunale MA, Lowman M et al (2005) Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A 102:779–784PubMedCrossRefGoogle Scholar
  9. 9.
    Patwa TH, Zhao J, Anderson MA, Simone DM et al (2006) Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection. Anal Chem 78:6411–6421PubMedCrossRefGoogle Scholar
  10. 10.
    Chen SM, LaRoche T, Hamelinck D et al (2007) Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat Methods 5:437–444Google Scholar
  11. 11.
    Zhao J, Patwa TH, Qiu WL et al (2007) Glycoprotein microarray with multi-lectin detection: unique lectin binding patterns as tools for classifying normal, chronic pancreatitis, and pancreatic cancer sera. J Proteome Res 5:1864–1874CrossRefGoogle Scholar
  12. 12.
    Wu YM, Nowack DD, Omenn GS et al (2008) Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. Pancreas 37:502Google Scholar
  13. 13.
    Yue TT, Goldstein IJ, Hollingsworth MA et al (2009) The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Mol Cell Proteomics 7:1697–1707Google Scholar
  14. 14.
    Evans-Nguyen KM, Tao SC, Zhu H et al (2008) Protein arrays on patterned porous gold substrates interrogated with mass spectrometry: detection of peptides in plasma. Anal Chem 5:1448–1458CrossRefGoogle Scholar
  15. 15.
    Li C, Simeone DM, Brenner DE et al (2009) Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res 8:483–492PubMedCrossRefGoogle Scholar
  16. 16.
    Nyboa M, Olsenb H, Jeuneb B et al (1998) Increased plasma concentration of serum amyloid P component in centenarians with impaired cognitive performance. Dement Geriatr Cogn 9:126–129CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of ChemistryThe University of MichiganAnn ArborUSA
  2. 2.Department of Chemistry, Comprehensive Cancer CenterThe University of MichiganAnn ArborUSA
  3. 3.Department of SurgeryThe University of Michigan Medical CenterAnn ArborUSA

Personalised recommendations